Hjem › Non-Hodgkins lymfom › Oregon › Portland
Kliniske studier for Non-Hodgkins lymfom i Portland, OR
15 studier for Non-Hodgkins lymfom søker deltakere på steder i og rundt Portland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RekruttererFase 1/2
- Oregon Health and Sciences University, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Providence Health & Services, Portland
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- Oregon Health & Science University (OHSU), Portland
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Portland
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RekruttererFase 2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- Oregon Health & Science University, Portland
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekruttererObservasjonsstudie
- Oregon Health and Science University Knight Cancer Institute, Portland
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Oregon Health and Science University Knight Cancer Institute, Portland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Providence Neurological Specialties West, Portland
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Kaiser Permanente Northwest, Portland
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- Oregon Health and Science University - Knight Cancer Institute, Portland
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
RekruttererObservasjonsstudie
- Local Institution - 0016, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Portland
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- Oregon Health & Science University, Portland
Non-Hodgkins lymfom-studier i andre byer
- New York City, NY31 studier
- Houston, TX31 studier
- Boston, MA26 studier
- Nashville, TN21 studier
- Philadelphia, PA20 studier
- Baldwin Park, CA19 studier
- Washington, DC18 studier
- Chicago, IL18 studier
- Atlanta, GA18 studier
- Milwaukee, WI18 studier
- Columbus, OH18 studier
- Dallas, TX17 studier
Andre studier i Portland
- Ikke-småcellet lungekreft46 studier
- Kreft (alle typer)34 studier
- Brystkreft33 studier
- Prostatakreft33 studier
- Metastatisk kreft29 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Lungekreft26 studier
- Akut myelogen leukemi25 studier
- Endometriekreft24 studier
- Plateepitelcancer i hode og hals19 studier
- Pankreaskreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.